Page results
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
UCLH vision, values and strategy
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page explains what an intra-oral scanner is and what it is used for.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
File results
-
FOI/2024/0627 - E-signature vendor supplier and cost
-
FOI/2024/0634 - Private Finance Initiative (PFI) and Private Finance 2 (PF2) projects repayments and debt
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0641 - Chief Nursing Information Officer (CNIO)/ chief midwifery information officer (CMIO)
-
FOI/2024/0645 - Electronic Patient Record (EPR) systems usage, expenditure, contract and digital maturity
-
FOI/2024/0646 - Management of Combine Heat and Power (CHP) units
-
FOI/2024/0647 - Treatment of rare diseases; Fabry/ Gaucher/ Pompe disease
-
FOI/2024/0650 - Framework used for Radiology Information System (RIS)
-
FOI/2024/0653 - Sterile services/ decontamination units
-
FOI/2024/0659 - Treatment of cancers; breast/ prostate/ ovarian and endometrial